Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice

• Main Authors: Lieqiang Xu (Author), Juanjuan Cheng (Author), Jieyi Lu (Author), Guoshu Lin (Author), Qiuxia Yu (Author), Yucui Li (Author), Jiannan Chen (Author), Jianhui Xie (Author), Ziren Su (Author), Qi Zhou (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hyperuricemia (HUA), a common metabolic disease, is treated as the second-largest metabolic disease after diabetes in China. Cortex Phellodendri (CP) is one of the most frequently used herbal medicines for treating gout or HUA. However, the mechanism underlying the anti-HUA effect of CP is still unr...